Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limited (Lilly) have signed a ...

When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

Elon Musk's AI chatbot, Grok, is being used by X users for medical image analysis, raising both hopes and concerns. While ...

Eli Lilly Saudi Arabia and King Faisal Specialist Hospital & Research Centre (KFSHRC) have teamed up to make KFSHRC’s Neuroscience Centre a top regional hub for Alzheimer’s disease treatment.

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to improve Alzheimer's patient care.

WAUSAU, Wis. (WSAW) - The University of Wisconsin School of Medicine and Public Health in Madison’s nationwide CLARiTI research study aims to find data that makes dementia-related diagnoses ...

Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...